Skip to content Skip to search

Republish This Story

* Please read before republishing *

We’re happy to make this story available to republish for free under an Attribution-NonCommercial-NoDerivatives Creative Commons license as long as you follow our republishing guidelines, which require that you credit The 19th and retain our pixel. See our full guidelines for more information.

To republish, simply copy the HTML at right, which includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to The 19th. Have questions? Please email [email protected].

— The Editors

Loading...

Modal Gallery

/
Donate to our newsroom

Menu

Topics

  • Abortion
  • Politics
  • Education
  • LGBTQ+
  • Caregiving
  • Environment & Climate
  • Business & Economy
View all topics

The 19th News(letter)

News that represents you, in your inbox every weekday.

You have been subscribed!

Please complete the following CAPTCHA to be confirmed. If you have any difficulty, contact [email protected] for help.

Submitting...

Uh-oh! Something went wrong. Please email [email protected] to subscribe.

This email address might not be capable of receiving emails (according to Bouncer). You should try again with a different email address. If you have any questions, contact us at [email protected].

  • Latest Stories
  • Our Mission
  • Our Team
  • Ways to Give
  • Search
  • Contact
Donate
Home

We’re an independent, nonprofit newsroom reporting on gender, politics and policy. Read our story.

Topics

  • Abortion
  • Politics
  • Education
  • LGBTQ+
  • Caregiving
  • Environment & Climate
  • Business & Economy
View all topics

The 19th News(letter)

News that represents you, in your inbox every weekday.

You have been subscribed!

Please complete the following CAPTCHA to be confirmed. If you have any difficulty, contact [email protected] for help.

Submitting...

Uh-oh! Something went wrong. Please email [email protected] to subscribe.

This email address might not be capable of receiving emails (according to Bouncer). You should try again with a different email address. If you have any questions, contact us at [email protected].

  • Latest Stories
  • Our Mission
  • Our Team
  • Ways to Give
  • Search
  • Contact

We’re an independent, nonprofit newsroom reporting on gender, politics and policy. Read our story.

The 19th News(letter)

News that represents you, in your inbox every weekday.

You have been subscribed!

Please complete the following CAPTCHA to be confirmed. If you have any difficulty, contact [email protected] for help.

Submitting...

Uh-oh! Something went wrong. Please email [email protected] to subscribe.

This email address might not be capable of receiving emails (according to Bouncer). You should try again with a different email address. If you have any questions, contact us at [email protected].

Become a member

The 19th thanks our sponsors. Become one.

Abortion

Federal judges uphold abortion pill restrictions, pending Supreme Court approval

If it took effect, the decision could bar mifepristone, one of two drugs used in medication abortions, from being provided over telemedicine, limiting clinics’ capacity.

Demonstrators rally in support of abortion rights at the Supreme Court in Washington, D.C. in April 2023.
Demonstrators rally in support of abortion rights at the Supreme Court in Washington, D.C., in April 2023. (Andrew Caballero-Reynolds/AFP/Getty Images)

Shefali Luthra

Reproductive Health Reporter

Published

2023-08-16 14:31
2:31
August 16, 2023
pm

Republish this story

Share

  • Bluesky
  • Facebook
  • Email

Republish this story

Your trusted source for contextualizing abortion news. Sign up for our daily newsletter.

Federal judges ruled Wednesday that access to mifepristone, one of two drugs used in medication abortions, should be heavily restricted, but their decision won’t immediately change access to the pill.

The three-judge panel on the U.S. Court of Appeals for the 5th Circuit held that mifepristone can only be used up to seven weeks of pregnancy, and it can only be prescribed in person. It is currently approved for use until the tenth week of pregnancy, though health care providers will often prescribe it through the end of the first trimester. Evidence has also shown the drug is safe to be provided over telemedicine. The court’s decision would revert availability back to what the Food and Drug Administration approved in 2016.

The 19th thanks our sponsors. Become one.

But the ruling by itself won’t change access. In their decision, the judges wrote that their verdict is subject to approval by the U.S. Supreme Court, which in April ruled to block a lower court from tightening restrictions on how mifepristone is dispensed.

The case was brought by a collection of anti-abortion doctors, who have been seeking to undo the FDA’s approval for mifepristone entirely. The judges rejected that request, arguing that the drug, which was approved in 2000, had been on the market for too long, and rescinding approval would likely violate a statute of limitations.

It’s not clear when the Supreme Court will weigh in on this case. 

  • More abortion coverage
    People vote at a polling location in Columbus, Ohio on November 8, 2022.
  • How data from abortion rights fights in 2022 could shape 2024
  • Federal judges seem open to restricting access to mifepristone abortion pill
  • An abortion pill distributor reportedly won’t supply the drug to pharmacies in 31 states. House Democrats want answers.

The three-judge panel heard this case in May. At the time, their questioning focused on the issue of standing — whether the doctors suing had the right to challenge mifepristone’s availability, and if they could prove they had been harmed by its approval. 

Critically, the judges ruled that the doctors had shown they had the right to sue. That could be influential whenever the high court hears this case. 

““The working assumption is the Supreme Court will be on board with whatever when it comes to the merits, but there are problems with standing and timeliness,” Mary Zieger, an abortion law expert at the University of California Davis, told The 19th at the time. “The 5th Circuit is throwing its lot in with the plaintiffs and trying to help them convince the Supreme Court.”

A case like this is without precedent. If the judges’ ruling were to take effect, it could have major implications across the country. Abortion clinics in states flooded by out-of-state patients have relied on telemedicine as a way to expand capacity; the service has also helped providers reach patients who live in rural areas. In addition to the FDA, medical authorities such as the World Health Organization have also endorsed telemedicine for medication abortion.

Republish this story

Share

  • Bluesky
  • Facebook
  • Email

Recommended for you

Demonstrators rally in support of abortion rights at the Supreme Court in Washington, D.C.
Federal judges seem open to restricting access to mifepristone abortion pill
Two protesters hug each other during a candlelight vigil in front of the Supreme Court.
Supreme Court temporarily blocks mifepristone restrictions in a rare win for abortion rights
A Box of Mifepristone Pills photo was taken at a pharmacy in Tehatta, West Bengal; India on 18/08/2023.
Many people now rely on telehealth to access abortion pills — but the Supreme Court could change that
Supreme Court dismisses case that would have limited abortion pill access

The 19th News(letter)

News that represents you, in your inbox every weekday.

You have been subscribed!

Please complete the following CAPTCHA to be confirmed. If you have any difficulty, contact [email protected] for help.

Submitting...

Uh-oh! Something went wrong. Please email [email protected] to subscribe.

This email address might not be capable of receiving emails (according to Bouncer). You should try again with a different email address. If you have any questions, contact us at [email protected].

Become a member

Explore more coverage from The 19th
Abortion Politics Education LGBTQ+ Caregiving
View all topics

Our newsroom's Spring Member Drive is here!

Learn more about membership.

  • Transparency
    • About
    • Team
    • Contact
    • Privacy Policy
    • Community Guidelines
  • Newsroom
    • Latest Stories
    • 19th News Network
    • Podcast
    • Events
    • Careers
    • Fellowships
  • Newsletters
    • Daily
    • Weekly
    • The Amendment
    • Event Invites
  • Support
    • Ways to Give
    • Sponsorship
    • Republishing
    • Volunteer

The 19th is a reader-supported nonprofit news organization. Our stories are free to republish with these guidelines.